Does HRT Help IBS Symptoms? What Studies and Guidelines Say

Does HRT help IBS symptoms? Not reliably. HRT isn't a recognized treatment for irritable bowel syndrome, and no trial we found tested it for IBS. Two large records studies linked HRT use to more new IBS diagnoses, while a small survey found estrogen didn't change gut symptoms. IBS has its own treatments, and those work alongside menopause care.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

What we actually verified · Last verified October 2026

• What we read: the American College of Gastroenterology's 2021 clinical guideline on IBS; the NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) pages on IBS definition, symptoms, diagnosis, treatment and diet; the full text of a 2010 meta-analysis of IBS symptoms in men and women, two reviews of ovarian hormones and IBS, a 2020 study comparing IBS in women before and after menopause, and two Seattle Midlife Women's Health Study papers on bowel symptoms and belly pain during the menopause transition; PubMed abstracts of a UK study of HRT and IBS risk, a 1998 survey of bowel symptoms after menopause, a 2006 trial of estradiol and progesterone on gut transit and a 2026 Seattle study of bloating; a 2024 American College of Gastroenterology meeting abstract on HRT and IBS; The Menopause Society's 2022 hormone therapy and 2023 nonhormone therapy position statements; and the FDA labels for Prometrium (progesterone) and the Climara estradiol patch. Every source is listed at the bottom with the date we read it.
• What we did not do: we did not examine anyone, review anyone's records or test results, or speak with a clinician for this page. This is editorial research, not medical review, and not advice for your situation.
• Commercial interest: The HRT Index may earn a commission from some providers featured through The HRT Index's Find My HRT Path tool. No provider paid for this page, and no provider reviewed it. See our affiliate disclosure.
• Verification Standard: we judge online menopause care on five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency and access. Our methodology explains how.

Jump to: Quick answer by situation · IBS and menopause · Does HRT help or worsen IBS? · Estrogen and progesterone · What the labels say · What actually treats IBS · Red flags · Who shouldn't take HRT · Questions to ask · Online care · FAQ · Sources

Does HRT help IBS symptoms? A quick answer for your situation

IBS and menopause often overlap in time. Belly pain, bloating, constipation and diarrhea can show up or change in your 40s and 50s, right when hot flashes and sleep problems start. That's why so many women wonder whether hormones are behind their gut symptoms, and whether hormone therapy could fix them. The short version is that HRT and IBS treatment do different jobs. Here is how the evidence we read applies to common situations.

The right online menopause care isn't the same for every woman — it depends on your symptoms, what you've already tried, your age, your state and your health history. Some situations belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to explore a featured care option for your situation — and to flag when online care isn't the right starting point — before your first consult.

Find My HRT Path is free, takes about 60 seconds and doesn't ask for your email. It asks about your symptoms (the options are menopause symptoms such as hot flashes, sleep, mood and vaginal dryness, not gut symptoms), what you've tried, your age, your state and your health history. Then it shows a featured care option or flags when in-person care makes more sense. It is not a diagnosis, and it does not decide whether you should be prescribed anything. It can't tell you whether you have IBS.

What is IBS, and why does it come up around menopause?

Irritable bowel syndrome is "a group of symptoms that occur together," according to the NIDDK. Those symptoms are repeated pain in the abdomen and changes in bowel movements, which may be diarrhea, constipation or both. With IBS, these symptoms happen "without any visible signs of damage or disease" in the digestive tract.

Doctors now call IBS a disorder of gut-brain interaction. Both the NIDDK and the 2021 American College of Gastroenterology (ACG) guideline use that term. It means the problem is in how the brain and gut work together. NIDDK explains that this can make the gut more sensitive, so you feel more pain and bloating, and can change how the bowel muscles contract, which leads to diarrhea, constipation or both.

IBS is common. NIDDK says studies suggest about 12% of people in the United States have it. The ACG guideline gives a prevalence of about 4.4% to 4.8% in the United States, United Kingdom and Canada. Estimates vary. Both sources agree on who is most affected: NIDDK says women are up to two times more likely than men to develop IBS, and people under 50 are more likely to develop it than people over 50.

IBS isn't dangerous in the way some other gut conditions are. NIDDK says it "can be painful but doesn't lead to other health problems or damage your digestive tract." That's one of the main differences from inflammatory bowel disease (IBD), which does cause inflammation and damage. If you have Crohn's disease or ulcerative colitis, our page on whether you can take HRT with inflammatory bowel disease covers that different question.

The three main types of IBS

NIDDK describes three types, based on the stools on days when at least one bowel movement isn't normal:

• IBS with constipation (IBS-C): more than a quarter of stools are hard or lumpy, and less than a quarter are loose or watery.
• IBS with diarrhea (IBS-D): more than a quarter of stools are loose or watery, and less than a quarter are hard or lumpy.
• IBS with mixed bowel habits (IBS-M): more than a quarter are hard or lumpy and more than a quarter are loose or watery.

The type matters for treatment. NIDDK notes that some medicines work only for some types of IBS or make other types worse. It also matters for the hormone question, because the studies below found hormones may push stools in one direction or the other.

Why IBS and menopause get tangled together

Several things in the research make women suspect a hormone link:

• IBS often tracks the menstrual cycle. NIDDK says women with IBS "often have more symptoms during their periods." A 2010 meta-analysis found that both women with IBS and women without it reported more IBS symptoms during menses than at other points in the cycle.
• Gut symptoms rise at times of low or falling hormones. A 2009 review in Gender Medicine concluded that the increase in gut symptoms "around the time of menses and early menopause occurs at times of declining or low ovarian hormones." The authors suggested estrogen and progesterone withdrawal "may contribute either directly or indirectly," and called for more research.
• Bowel changes are common around midlife. In a 1998 survey of 228 women at a women's health primary care practice, 38% of postmenopausal women reported altered bowel function, compared with 14% of premenopausal women. IBS-type complaints peaked at 36% in women aged 40 to 49.
• Women with IBS may have worse symptoms after menopause. A 2020 UCLA study of 242 women with IBS found postmenopausal women had more severe overall IBS symptoms than premenopausal women. There was no similar difference between older and younger men with IBS.

But the picture isn't simple. A 2010 review in Gastroenterologia Polska said data on how the menopause transition affects IBS "are inconsistent," and that after menopause the number of new IBS cases "generally decreases significantly." The 1998 survey also noted that the role of aging itself "cannot be ruled out." And the large Seattle Midlife Women's Health Study, which followed women through the transition with daily diaries and urine hormone tests, found that "key reproductive hormones do not play a significant role in constipation or diarrhea severity" during the menopause transition. Stress, tension, anxiety and the stress hormone cortisol did.

If bloating is your main complaint, our page on menopause and bloating covers that symptom in depth. If nausea is part of the picture, see menopause and nausea.

Does HRT help or worsen IBS? What the studies found

This is the core of the question, and the honest answer is that the evidence is thin, mostly observational, and leans toward HRT being linked with more IBS, not less. No randomized trial we found tested HRT as a treatment for IBS in women around menopause.

Studies linking HRT with more IBS diagnoses

The UK General Practice Research Database study (2003). Researchers followed 40,119 women aged 50 to 69 who had at least one HRT prescription between 1994 and 1999, and an age-matched group of 50,000 women who had never used HRT. New IBS was diagnosed at a rate of 3.8 per 1,000 person-years among HRT users, compared with 1.7 among never-users. Both current and past HRT users had a higher risk of IBS after the researchers adjusted for other health problems and how often women saw their doctor. The higher risk showed up "irrespective of treatment duration, regimen or route of administration." That means it didn't matter how long women took HRT, which regimen they used, or whether it was a pill, patch or another form.

A US health records study (2024). A study presented as an abstract at the American College of Gastroenterology's 2024 meeting used the TriNetX health records network. It compared postmenopausal women aged 50 or older who had an HRT prescription (estrogen and progesterone) with matched women who didn't, at 46,627 women per group. New IBS was diagnosed in 992 women on HRT and 581 women not on HRT, an odds ratio of 1.75. The link held over five years. It showed up for all three IBS types, and was strongest for IBS with constipation (odds ratio 2.27). Women on HRT were also more likely to have bloating recorded, to be prescribed IBS medicines and to have a colonoscopy.

That second study is a meeting abstract, not a full peer-reviewed paper, so it carries less weight. But it points in the same direction as the UK study.

Why those studies don't prove HRT causes IBS

Both studies show an association, not cause and effect. Researchers have offered other explanations:

• Women with IBS may be more likely to get HRT. The 2009 Gender Medicine review and the 2010 Gastroenterologia Polska review both raise this. Women with IBS may be more likely to report menopause symptoms such as hot flashes and insomnia, "and thus may be prescribed HRTs to a greater degree."
• Women on HRT may see clinicians more. More visits can mean more chances for a diagnosis to be recorded. The UK study tried to account for this by adjusting for consultation patterns. The US abstract matched for age, race, ethnicity and some gut conditions, but its abstract doesn't say it adjusted for visit frequency.
• Records studies rely on diagnosis codes. They can't measure how bad symptoms were day to day. The UK study did check its IBS diagnoses with a questionnaire sent to general practitioners.

The 2010 Gastroenterologia Polska review summed up the uncertainty: HRT "may prolong IBS symptoms to a later age or even induce changes in GI function in women not affected previously," but women with IBS may also simply be prescribed HRT more often.

Studies that found no clear effect

Severity didn't differ in the UK data. A 2010 meta-analysis in Alimentary Pharmacology & Therapeutics reviewed the UK study and reported that, although HRT users were more likely to develop IBS, "the prevalence and severity of IBS symptoms were similar" among HRT users and non-users.

Estrogen didn't change symptoms in the 1998 survey. The survey of 228 women that found high rates of bowel changes after menopause also reported that "estrogen use did not affect gastrointestinal symptoms" in either the premenopausal or the postmenopausal group.

The overall verdict: not enough data. After reviewing the studies of hormones and IBS, the 2010 meta-analysis concluded: "There were insufficient data to determine the effect of menopause and hormone supplementation on IBS symptoms."

The 2020 UCLA study couldn't answer it. That study found worse IBS after menopause, but only 2 of its 52 postmenopausal women (3.85%) were using HRT. So it tells us about menopause and IBS, not about HRT and IBS.

What we didn't find

We didn't find a randomized trial showing that HRT improves IBS symptoms in women with IBS. We didn't find a guideline, from gastroenterology or menopause societies, that recommends HRT to treat IBS. The ACG's 2021 IBS guideline doesn't list hormone therapy among its treatments, and The Menopause Society's 2022 hormone therapy statement describes hormone therapy as the most effective treatment for hot flashes and night sweats and for genitourinary syndrome of menopause, not for gut symptoms.

That doesn't mean no woman with IBS feels better on HRT. Better sleep or fewer night sweats might make a hard day easier. But the research we read doesn't support taking HRT to treat IBS itself.

What estrogen and progesterone do in the gut

Estrogen and progesterone do act on the gut, which is why the question makes sense. But the effects researchers have measured are mixed, and they don't add up to a treatment.

Short-term hormone doses loosened stools in one trial

In a 2006 Mayo Clinic trial, 49 healthy postmenopausal women were randomly assigned to take micronized progesterone, estradiol, both, or a placebo for 7 days. The researchers measured how fast food and waste moved through the gut with a scan.

• Progesterone sped up movement through part of the colon.
• Estradiol alone and the combination didn't change transit compared with placebo.
• Estradiol and progesterone both led to looser stool consistency.
• Stopping the hormones didn't significantly change transit.

The authors concluded: "Micronized progesterone does not retard colonic transit in postmenopausal females." In plain terms, progesterone didn't slow the bowel down, which some women expect it to do. The 2010 meta-analysis described the same trial: the women given estradiol or progesterone "were more likely to have looser stools and greater ease of passage" than those on placebo.

This was a one-week study in women without IBS. It can't tell you how HRT will affect IBS over months. But it suggests why some women notice a change in their bowel habits after starting hormones, and why the direction of change might matter. Looser stools could feel like relief with constipation and like a problem with diarrhea. That's our reading of the study, not something it tested, so it's a question to raise with your clinician rather than a reason to choose or avoid a product.

Hormone levels and day-to-day symptoms

The Seattle Midlife Women's Health Study followed 291 women aged 35 to 55 from 1990 to 2013 with daily diaries and annual questionnaires. A subset gave urine samples so researchers could measure hormones and stress markers.

• Constipation and diarrhea (2018 paper): the authors concluded that "key reproductive hormones do not play a significant role in constipation or diarrhea severity" during the transition. "In contrast, stress perception, tension, anxiety, and cortisol do."
• Belly pain (2019 paper): age, anxiety and a urine estrogen measure were each linked to belly pain severity. Higher estrogen and older age went with less pain, and anxiety went with more. Stage of the menopause transition wasn't linked.
• Bloating (2026 paper): the early and late stages of the menopause transition were linked to more severe bloating. Tension was linked to more bloating, and age and testosterone levels were linked to less.

These studies measured women's own hormone levels, not hormone therapy. They suggest hormones are only one part of midlife gut symptoms, alongside stress and anxiety. That fits how IBS is treated: as a gut-brain condition. If anxiety is part of your picture, our page on whether progesterone helps with anxiety looks at that separate question.

Estrogen's effects can cut both ways

The 2010 Gastroenterologia Polska review noted that many results on sex hormones and the gut, "especially for estrogens, appear to be inconsistent or even contradictory." Lab and animal research suggests estrogen can affect pain signals, gut sensitivity and gut movement, but not always in the same direction. That's one reason researchers haven't been able to predict who might feel better or worse on HRT.

What the HRT labels say about gut side effects

The FDA-approved labels list gut symptoms among possible side effects. That matters if you already have IBS, because a new side effect can be hard to tell apart from a flare.

Prometrium (micronized progesterone). In a 3-year placebo-controlled trial in postmenopausal women, Prometrium was taken with conjugated estrogens. The label's table of side effects reported:

The label's patient information also lists "stomach or abdominal cramps, bloating" and "nausea and vomiting" among "less serious, but common side effects." Our page on progesterone side effects in menopause and our guide to micronized progesterone side effects go into more detail.

Climara (estradiol patch). The Climara label lists vomiting, abdominal pain, abdominal distension and nausea among gut reactions reported after the product was approved. The label notes that reports like these come from a population of uncertain size, so it isn't always possible to estimate how often they happen or to prove the drug caused them. See estradiol patch side effects and our overview of HRT side effects.

Neither label lists IBS as a reason not to use the medicine. But both show that bloating and belly discomfort can come with HRT. If you have IBS, it helps to note your usual symptoms before starting, so you and your clinician can tell whether anything changes. Our page on oral vs. transdermal estrogen explains the difference between pills and patches. Note that the UK study found the higher IBS risk regardless of route, so a patch isn't proven to be easier on the gut.

What actually treats IBS?

IBS has its own treatment plan, and it doesn't involve hormones. The ACG's 2021 guideline and NIDDK describe several approaches. NIDDK says you may have to try a few treatments to see what works best for you, and your doctor can help you find the right plan. This section summarizes what they say. It isn't a plan for you, and we don't give doses.

Getting the diagnosis right

The ACG recommends a "positive diagnostic strategy" rather than testing to rule out everything first. That means a clinician can diagnose IBS from your symptom pattern, a physical exam and a small set of tests, so treatment can start sooner.

NIDDK describes the symptom pattern doctors look for: belly pain along with two or more of these:

• the pain is related to bowel movements, for example it improves or gets worse after them
• a change in how often you have a bowel movement
• a change in how your stools look

Doctors may diagnose IBS if you've had symptoms at least once a week in the last 3 months and they first started at least 6 months ago. NIDDK adds that your doctor may diagnose IBS even if you've had symptoms for a shorter time.

For people with diarrhea symptoms, the ACG recommends a blood test to rule out celiac disease. It suggests a stool test (fecal calprotectin or lactoferrin) and a blood test (C-reactive protein) to rule out inflammatory bowel disease in people without alarm features. It recommends against routine colonoscopy in people with IBS symptoms younger than 45 who have no warning signs. NIDDK lists other tests a doctor might use depending on your situation, including a hydrogen breath test, an upper endoscopy with biopsy to check for celiac disease, and a colonoscopy.

Diet and fiber

• Low FODMAP diet: the ACG recommends "a limited trial" of a low FODMAP diet to improve overall IBS symptoms. FODMAPs are carbohydrates that are hard to digest. NIDDK says you may try the diet for a few weeks and, if symptoms improve, slowly add foods back. A dietitian can help.
• Fiber: the ACG suggests soluble, but not insoluble, fiber. NIDDK says soluble fiber is found in beans, fruit and oat products, and that adding fiber slowly, by 2 to 3 grams a day, may help prevent gas and bloating.
• Gluten: NIDDK says your doctor may recommend avoiding gluten to see if symptoms improve, because some people with IBS have more symptoms after eating it even without celiac disease.

Medicines

The ACG and NIDDK list prescription and over-the-counter options that depend on your IBS type:

• For IBS with diarrhea: NIDDK lists loperamide, rifaximin, eluxadoline and alosetron. NIDDK notes alosetron "is prescribed only to women and is prescribed with special warnings and precautions," and the ACG recommends it for women with severe IBS-D who haven't improved with conventional therapy.
• For IBS with constipation: NIDDK lists fiber supplements, laxatives, lubiprostone, linaclotide and plecanatide. The ACG recommends chloride channel activators and guanylate cyclase activators for IBS-C.
• For belly pain: NIDDK lists antispasmodics, low doses of tricyclic antidepressants and SSRIs, and coated peppermint oil capsules. The ACG recommends tricyclic antidepressants for overall IBS symptoms and suggests peppermint. It recommends against the antispasmodics currently available in the United States for overall IBS symptoms.

The ACG suggests against probiotics for overall IBS symptoms. NIDDK says researchers are still studying them and advises talking with your doctor before using probiotics. Always follow your own clinician's advice on any medicine, including over-the-counter ones.

Gut-brain therapies

Because IBS is a gut-brain condition, therapy aimed at that connection is part of treatment. The ACG suggests gut-directed psychotherapies. NIDDK lists cognitive behavioral therapy, gut-directed hypnotherapy and relaxation training.

There's an interesting overlap here. The Menopause Society's 2023 nonhormone therapy statement recommends cognitive behavioral therapy and clinical hypnosis for hot flashes, and it recommends SSRIs and SNRIs too. Some of the same kinds of treatment appear on both lists. Whether any one option suits both your IBS and your menopause symptoms is a question for your clinicians. See our guide to nonhormonal options for menopause symptoms.

Lifestyle

NIDDK says research suggests more physical activity, reducing stressful situations where possible, and getting enough sleep may help IBS symptoms. Sleep is one place menopause care can matter: if night sweats are wrecking your sleep, treating them might make other things easier to manage. That's a reason to treat menopause symptoms on their own merits, not evidence that HRT treats IBS.

When gut symptoms need in-person care first

Not every gut symptom around menopause is IBS, and some need to be checked in person promptly. NIDDK says these symptoms may suggest a health problem other than IBS:

• anemia
• bleeding from the rectum
• bloody stools, or stools that are black and tarry
• weight loss

The ACG guideline lists similar "alarm features": blood in the stool, black stools, weight loss you didn't intend, symptoms that start at an older age, and a family history of inflammatory bowel disease, colon cancer or other significant gut disease. NIDDK says doctors will also ask about a family history of celiac disease, colon cancer or IBD.

The ACG also says colon cancer screening is a separate consideration for people with IBS. Having an IBS diagnosis doesn't replace age-appropriate screening, so ask your clinician whether you're up to date.

See a clinician in person if:

• you have any of the warning signs above
• your symptoms are new and started in midlife, and you haven't been evaluated
• your symptoms changed sharply from your usual IBS pattern
• you have severe or worsening belly pain
• you're starting or already taking HRT and develop new belly pain that's different from your usual symptoms

The Menopause Society's 2022 statement notes that estrogen therapy and combined estrogen-progestogen therapy are associated with a rare increased risk of gallbladder disease. That's one more reason to report new or different belly pain on HRT rather than assuming it's your IBS.

If you have one of the conditions below, which affect whether hormones are an option at all, start with an in-person clinician too.

Who shouldn't take HRT, whatever their IBS

IBS isn't on the contraindication lists in the labels we read. The conditions that are listed are the same whether or not you have IBS.

The Prometrium label says it shouldn't be used by women with:

• allergy to its ingredients, including peanuts (the capsules contain peanut oil)
• abnormal genital bleeding without a known cause
• known, suspected or past breast cancer
• active deep vein thrombosis or pulmonary embolism, or a history of them
• active arterial clotting disease, such as a stroke or heart attack, or a history of it
• known liver problems or liver disease

The Climara estradiol patch label lists undiagnosed abnormal genital bleeding; breast cancer or a history of it; estrogen-dependent cancers; active or past blood clots in the legs or lungs; active or past stroke or heart attack; known allergic reactions to the product; liver problems or disease; and protein C, protein S or antithrombin deficiency or other known clotting disorders.

The Menopause Society's 2022 statement says that for women younger than 60 or within 10 years of menopause onset who have no contraindications, the benefit-risk ratio is favorable for treating bothersome hot flashes and night sweats and for preventing bone loss. Risks differ by the type, dose, duration and route of hormone therapy, the timing of starting it, and whether a progestogen is needed. Our page on who should not take HRT goes into more detail.

Questions to ask your clinician

Bring these to your primary care clinician, gastroenterologist or menopause clinician:

1. "Do my symptoms fit IBS, or should we check for something else first? Do I need any tests?"
2. "Which type of IBS do I have: constipation, diarrhea or mixed? How does that change my options?"
3. "Am I up to date on colon cancer screening?"
4. "Should I try a low FODMAP diet, and can you refer me to a dietitian?"
5. "Would a gut-directed therapy, such as CBT or hypnotherapy, make sense for me?"
6. "Is HRT reasonable for my hot flashes, night sweats or sleep, given my IBS and my health history?"
7. "If I start HRT, how should I track my bowel habits, bloating and belly pain, and what changes should I report?"
8. "If my gut symptoms change on HRT, would changing the type or route make sense, or should we look for another cause?"
9. "Would a nonhormonal option for my menopause symptoms fit better with my IBS treatment?"

Can online menopause care help if you have IBS?

Online care can help with the menopause part of the picture, but it isn't where IBS gets diagnosed or managed. Here is how our five pillars apply:

• Clinical legitimacy: A licensed clinician should ask about your gut symptoms and your IBS history, not just your hot flashes. A responsible service should tell you when new gut symptoms or warning signs need an in-person evaluation first. Our page on whether online HRT is safe covers the warning signs of a poor service.
• Care quality: Good care means the clinician takes your IBS seriously when choosing a treatment, explains that bloating and belly cramps are possible side effects, and has a plan for follow-up if your bowel habits change. It also means they don't stop or replace your IBS treatment.
• Medication fit: HRT is a treatment for menopause symptoms such as hot flashes, night sweats and vaginal dryness. It isn't an IBS treatment. If your gut symptoms are your main concern, the right first step is IBS care, not HRT.
• Price transparency: Check what visits, medication and follow-ups cost before you start. IBS tests and gastroenterology visits are separate costs.
• Access: Online care can make it easier to get menopause treatment and follow-up without waiting for an in-person appointment. That can help if your IBS is already diagnosed and stable and your menopause symptoms are the problem.

A reasonable order for many women is: get gut symptoms evaluated in person, especially if they're new or include warning signs; start IBS-specific treatment; and then look at whether online menopause care fits your other menopause symptoms. If you have other conditions alongside IBS, such as fibromyalgia, our page on whether HRT helps fibromyalgia may help. Our perimenopause symptoms checklist can help you list what you're dealing with before a visit.

Frequently asked questions

Does HRT help IBS symptoms?

Not as a treatment for IBS. No guideline we read recommends HRT for IBS, and a 2010 meta-analysis found "insufficient data" on hormone therapy and IBS symptoms. Large records studies from the UK and US linked HRT use to more new IBS diagnoses. IBS is treated with diet changes, fiber, medicines and gut-brain therapies.

Can HRT make IBS worse?

It might for some women, but the evidence can't say for sure. A UK study found HRT users were diagnosed with IBS at about twice the rate of never-users, and a 2024 US abstract found a similar link. These studies can't prove cause. Bloating and belly cramps are listed side effects of progesterone.

Can menopause cause IBS?

Research hasn't shown that menopause causes IBS. Bowel changes are common around midlife, and one study found women with IBS had worse symptoms after menopause. But a review called the data "inconsistent," and new IBS cases generally decrease after menopause. The Seattle midlife research linked stress and anxiety, rather than reproductive hormones, to constipation and diarrhea severity.

Does estrogen help IBS?

The studies we read don't show that. A 1998 survey found estrogen use didn't affect gut symptoms. In a one-week trial in healthy postmenopausal women, estradiol made stools looser, which isn't the same as treating IBS. Researchers describe estrogen's effects on the gut as inconsistent.

Does progesterone cause constipation or diarrhea?

In a one-week trial, progesterone sped up part of the colon and loosened stools in healthy postmenopausal women, rather than slowing the bowel. On the Prometrium label, constipation was reported by 3% of women taking it with estrogen and 2% on placebo, and diarrhea by 7% and 4%. Bloating was more common: 12% compared with 5%.

Should I take HRT if I have IBS?

That's a decision for you and your clinician. IBS isn't on the contraindication lists in the progesterone and estradiol labels we read. HRT may make sense for bothersome hot flashes or night sweats, but not as an IBS treatment. Ask how you'll track gut symptoms after you start.

Is it IBS or something more serious?

Only a clinician can tell. NIDDK says anemia, bleeding from the rectum, bloody or black tarry stools, and weight loss can be signs of a different problem. A family history of colon cancer, celiac disease or IBD also matters. New symptoms in midlife deserve an evaluation, especially before you assume they're hormonal.

The bottom line

HRT doesn't treat IBS. No guideline we read recommends it for IBS, a 2010 meta-analysis found too little data to judge its effect on symptoms, and the largest studies linked HRT use to more IBS diagnoses, not fewer. IBS has its own effective tools: a clear diagnosis, diet changes such as a short low FODMAP trial, soluble fiber, medicines chosen for your IBS type, and gut-brain therapies. HRT can be a reasonable choice for hot flashes, night sweats and other menopause symptoms if you have IBS, as long as your clinician knows your gut history and you watch for changes.

If you're figuring out where menopause care fits alongside your IBS care, Find My HRT Path can help you see what fits and flag when in-person care should come first.

Related reading

• Menopause and bloating: what the evidence actually shows
• Can you take HRT with inflammatory bowel disease?
• Menopause and nausea
• Menopause and histamine intolerance
• Progesterone side effects in menopause
• HRT side effects
• Who should not take HRT

Sources

All sources were read on October 30, 2026.

1. Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. American Journal of Gastroenterology, 2021;116(1):17–44. https://webfiles.gi.org/links/PCC/ACG_Clinical_Guideline__Management_of_Irritable.11.pdf
2. National Institute of Diabetes and Digestive and Kidney Diseases. Definition and facts for irritable bowel syndrome. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/definition-facts
3. National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms and causes of irritable bowel syndrome. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/symptoms-causes
4. National Institute of Diabetes and Digestive and Kidney Diseases. Diagnosis of irritable bowel syndrome. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/diagnosis
5. National Institute of Diabetes and Digestive and Kidney Diseases. Treatment for irritable bowel syndrome. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/treatment
6. National Institute of Diabetes and Digestive and Kidney Diseases. Eating, diet, and nutrition for irritable bowel syndrome. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/eating-diet-nutrition
7. Ruigómez A, García Rodríguez LA, Johansson S, Wallander MA. Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome? Maturitas, 2003;44(2):133–140. PubMed abstract. https://pubmed.ncbi.nlm.nih.gov/12590009/
8. Khalil J, Sun Y, Kaelber DC, Lembo AJ, Song G. S793: Hormone replacement therapy is associated with increased risk of developing irritable bowel syndrome in post-menopausal women. American Journal of Gastroenterology, 2024;119(10S):S547. Meeting abstract. https://doi.org/10.14309/01.ajg.0001032540.54524.37
9. Triadafilopoulos G, Finlayson M, Grellet C. Bowel dysfunction in postmenopausal women. Women & Health, 1998;27(4):55–66. PubMed abstract. https://pubmed.ncbi.nlm.nih.gov/9796084/
10. Gonenne J, Esfandyari T, Camilleri M, et al. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterology & Motility, 2006;18(10):911–918. PubMed abstract. https://pubmed.ncbi.nlm.nih.gov/16961694/
11. Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Alimentary Pharmacology & Therapeutics, 2010;32(6):738–755. https://pmc.ncbi.nlm.nih.gov/articles/PMC2932820/
12. Heitkemper MM, Chang L. Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gender Medicine, 2009;6(Suppl 2):152–167. https://pmc.ncbi.nlm.nih.gov/articles/PMC3322543/
13. Mulak A, Taché Y. Sex difference in irritable bowel syndrome: do gonadal hormones play a role? Gastroenterologia Polska, 2010;17(2):89–97. https://pmc.ncbi.nlm.nih.gov/articles/PMC4244886/
14. Lenhart A, Naliboff B, Shih W, et al. Postmenopausal women with irritable bowel syndrome (IBS) have more severe symptoms than premenopausal women with IBS. Neurogastroenterology & Motility, 2020;32(10):e13913. https://pmc.ncbi.nlm.nih.gov/articles/PMC7529855/
15. Callan NGL, Mitchell ES, Heitkemper MM, Woods NF. Constipation and diarrhea during the menopause transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause, 2018;25(6):615–624. https://pmc.ncbi.nlm.nih.gov/articles/PMC8080720/
16. Callan NGL, Mitchell ES, Heitkemper MM, Woods NF. Abdominal pain during the menopause transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Women's Midlife Health, 2019;5:2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6679532/
17. Kamp KJ, Callan NGL, Mitchell ES, Heitkemper MM, Woods NF. Bloating during the menopause transition: observations from the Seattle Midlife Women's Health Study. Journal of Women's Health, 2026;35(9):834–839. PubMed abstract. https://pubmed.ncbi.nlm.nih.gov/42200334/
18. The 2022 hormone therapy position statement of The North American Menopause Society (The Menopause Society). Menopause, 2022;29(7):767–794. https://menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf
19. The 2023 nonhormone therapy position statement of The North American Menopause Society (The Menopause Society). Menopause, 2023;30(6):573–590. https://menopause.org/wp-content/uploads/professional/2023-nonhormone-therapy-position-statement.pdf
20. Prometrium (progesterone capsules) prescribing information. DailyMed, US National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1cf237ff-c4f8-4faa-a7aa-77599c856889
21. Climara (estradiol transdermal system) prescribing information. DailyMed, US National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e9702c4-f2d7-4ea8-b6e8-7dca31671864

This page is for education only and is not medical advice. It doesn't replace an examination, diagnosis or treatment plan from a clinician who knows your health history. If you have blood in your stool, black or tarry stools, unexplained weight loss or severe belly pain, see a clinician in person.